Activated BRAF targets proximal colon tumors with mismatch repair deficiency and MLH1 inactivation.
about
The links between axin and carcinogenesisCarcinogenesis and microsatellite instability: the interrelationship between genetics and epigeneticsReal-time PCR-based analysis of BRAF V600E mutation in low and intermediate grade lymphomas confirms frequent occurrence in hairy cell leukaemiaRASSF1A and NORE1A methylation and BRAFV600E mutations in thyroid tumors18q loss of heterozygosity in microsatellite stable colorectal cancer is correlated with CpG island methylator phenotype-negative (CIMP-0) and inversely with CIMP-low and CIMP-high.Mixed lineage kinase 3 gene mutations in mismatch repair deficient gastrointestinal tumours.Colorectal carcinomas with microsatellite instability display a different pattern of target gene mutations according to large bowel site of origin.Smoking, gender, and ethnicity predict somatic BRAF mutations in colorectal cancer.Molecular genetic analysis of 103 sporadic colorectal tumours in Czech patients.Genetic and epigenetic changes of components affecting the WNT pathway in colorectal carcinomas stratified by microsatellite instabilityBRAF mutations in aberrant crypt foci and hyperplastic polyposisBRAF screening as a low-cost effective strategy for simplifying HNPCC genetic testing.MLH1 promoter hypermethylation in the analytical algorithm of Lynch syndrome: a cost-effectiveness study.Target gene mutational pattern in Lynch syndrome colorectal carcinomas according to tumour location and germline mutationThe role of EGFR monoclonal antibodies (MoABs) cetuximab/panitumab, and BRAF inhibitors in BRAF mutated colorectal cancer.Genetic and epigenetic alterations of Ras signalling pathway in colorectal neoplasia: analysis based on tumour clinicopathological features.BRAF mutations and phosphorylation status of mitogen-activated protein kinases in the development of flat and depressed-type colorectal neoplasias.Molecular Biomarkers in the Personalized Treatment of Colorectal Cancer.BRAF(E600) in benign and malignant human tumours.MicroRNAs in the etiology of colorectal cancer: pathways and clinical implications.Diversity of axin in signaling pathways and its relation to colorectal cancer.Colorectal cancer and RASSF family--a special emphasis on RASSF1A.Importance of serrated polyps in colorectal carcinogenesis.AXIN1 and AXIN2 variants in gastrointestinal cancers.Microsatellite instability: an update.Targeting Wnt signaling in colorectal cancer. A Review in the Theme: Cell Signaling: Proteins, Pathways and Mechanisms.The co-regulatory networks of tumor suppressor genes, oncogenes, and miRNAs in colorectal cancer.Evidence of constitutional MLH1 epimutation associated to transgenerational inheritance of cancer susceptibility.Resequencing and copy number analysis of the human tyrosine kinase gene family in poorly differentiated gastric cancer.BRAF provides proliferation and survival signals in MSI colorectal carcinoma cells displaying BRAF(V600E) but not KRAS mutations.Hyperplastic Polyposis Syndrome Identified with a BRAF MutationB-Raf mutations, microsatellite instability and p53 protein expression in sporadic basal cell carcinomas.BRAF, KRAS and PIK3CA mutations in colorectal serrated polyps and cancer: primary or secondary genetic events in colorectal carcinogenesis?Microsatellite instability affecting the T17 repeats in intron 8 of HSP110, as well as five mononucleotide repeats in patients with colorectal carcinoma.Individual tumorigenesis pathways of sporadic colorectal adenocarcinomas are associated with the biological behavior of tumors.The prognostic role of microsatellite instability, codon-specific KRAS, and BRAF mutations in colon cancer.A simple immunohistochemical algorithm predicts the risk of distant metastases in right-sided colon cancer.Unmasking the role of KRAS and BRAF pathways in MSI colorectal tumors.Flat-type colorectal advanced adenomas (laterally spreading tumors) have different genetic and epigenetic alterations from protruded-type advanced adenomas.KRAS and BRAF oncogenic mutations in MSS colorectal carcinoma progression
P2860
Q24672469-1B303375-BA1E-4605-B914-BB04437D9ECBQ28253670-FEF68F90-F553-4832-BC9D-8F4D8F8F063DQ28257512-29E02E6F-A2E4-4A97-AA8B-210BEDA544EBQ28258450-5E140A5E-99EF-4492-905E-D93262BDF4A7Q33283458-87F17A80-74A8-439C-866D-84C655C971CEQ33594249-B7BAE048-2F74-4ADE-87AC-623607D1C931Q33729779-CAEFE563-C66C-426A-AFFE-60A7A923195DQ33857897-42FB56F3-6C0F-4F80-8F10-570E4469CEA9Q34013823-04E55FD4-E527-4713-A9E3-E8089E097222Q34768295-58A6AFB9-0FB9-4CAA-8F27-2F11C9680643Q35083792-6904D5E8-1F31-4DFC-B7FF-87C1055DB874Q35446668-45190578-8702-439C-8E2C-9E126B4ADE9AQ36035692-B52564EE-2BF0-4DF6-9DE6-AA837C679D1DQ36287080-605C270B-1E42-472A-872B-C58CE20C97DDQ36582552-4CB4DE30-7C0F-4943-BD02-31445F00EDAFQ36610632-0AB2A9B5-5C81-45D5-8B19-E533F1139DDBQ36613576-9E42D734-5296-437B-B441-8E927F9C7941Q36813582-0D8CC30D-90D5-4E63-AA86-DBACA4114467Q36921234-13617580-2C91-46D1-836C-6D0B803E379DQ37731180-C05C2BE6-626B-401C-B846-2D16D69C94A2Q37807331-E5584C45-8FA1-4D28-8C8C-11FA9773F65DQ38021701-F22FF59F-C989-48CA-AFF5-AFA983E3F930Q38053200-C728AA62-1B5B-4D2F-8E3D-5C9B41AE38D9Q38252534-E3536D00-1080-4F55-AFBF-4C865ABE6307Q38363519-8CC4F501-528B-4C2C-8124-F5F50F87232DQ38569786-444A3235-4D96-4943-ACFE-2F642B4C4423Q38694587-93EBFE13-A6EE-4688-AE85-63E8F41AA934Q39703413-956C9D60-E147-4B4D-AC31-6823D95D08C2Q39802930-C975DDDE-899A-4BA1-841F-6DA6165EEA29Q40031893-3790317B-1A1C-44F4-9EB1-30C561FAD94AQ42145847-E80375E3-139F-4181-9030-5B1B7C048C02Q42483165-6DAFB6BD-C458-413C-ABEB-68DED160CA6CQ42947711-5D4A23E0-04E9-484C-A1B2-812401D08246Q44160638-5B17E951-415A-4464-A373-E38F156C1E59Q46413296-79440DD5-4051-497F-989D-4FDD49B7C052Q48266694-59D0F9ED-0C38-4A9C-BE5B-D79653D66E43Q51436961-99FA5F44-6FA0-404A-A848-CFB6C9D48CD9Q51827376-1F19EF6F-EF75-49D7-B9FB-B52621C3C2A5Q54568995-4E0A4DC2-4DE2-4BBE-A233-453ABDCBD16FQ58966086-66C22EAA-AB18-4E76-ADFC-31A56793B206
P2860
Activated BRAF targets proximal colon tumors with mismatch repair deficiency and MLH1 inactivation.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年学术文章
@wuu
2004年学术文章
@zh
2004年学术文章
@zh-cn
2004年学术文章
@zh-hans
2004年学术文章
@zh-my
2004年学术文章
@zh-sg
2004年學術文章
@yue
2004年學術文章
@zh-hant
name
Activated BRAF targets proxima ...... iciency and MLH1 inactivation.
@en
Activated BRAF targets proxima ...... iciency and MLH1 inactivation.
@nl
type
label
Activated BRAF targets proxima ...... iciency and MLH1 inactivation.
@en
Activated BRAF targets proxima ...... iciency and MLH1 inactivation.
@nl
prefLabel
Activated BRAF targets proxima ...... iciency and MLH1 inactivation.
@en
Activated BRAF targets proxima ...... iciency and MLH1 inactivation.
@nl
P2093
P2860
P50
P356
P1476
Activated BRAF targets proxima ...... iciency and MLH1 inactivation.
@en
P2093
Alex Duval
Caroline Brennetot
Eloi Espín
Enric Domingo
Hiroyuki Yamamoto
Manel Armengol
Richard Hamelin
Simó Schwartz
P2860
P304
P356
10.1002/GCC.10310
P577
2004-02-01T00:00:00Z